<i>eIF2A</i> overexpression decreases the cell wall protein levels. by Laura Meyer (4033793)

A decrease in cellular RNA increases the insolubility of TDP-43. by Shinnosuke Takagi (428655)

In the absence of chloride, two-fold decrease in [Na⁺]_e shifted GLT-1a E_rev by −28 mV at both low and high glutamate concentrations. by Anatoli Y. Kabakov (729047)

Increased B-ADAM10 and decreased ADAM17 and TNF in Th2 biased strains. by Lauren Folgosa Cooley (733432)

JNJ26993135 + BML-111 decreases permeability and enhances ZO-1 and claudin-1 induced by PAF but does not change TEER. by Kameljit K. Kalsi (16496511)

The cyclic AMP analog 8-bromo-cAMP decreased transport of HIV-1 across BMEC (panel A) and at the 0.3 mM dose increased TEER (panel B). by Shinya Dohgu (285633)

HVR1-swap compensatory E1/E2 substitutions typically decrease virus entry dependency on SR-BI. by Christina Holmboe Olesen (11154333)

GO analysis of stage-salient genes in the order of decreasing significance (i.e, increasing p–value). by Sangeetha Muthamilselvan (8966006)

Decreased β-cell mass in Hq mutant mice. by Fabienne T. Schulthess (13268705)

Allergic patient B cells exhibit increased ADAM10 and sCD23 but decreased ADAM17 and TNF. by Lauren Folgosa Cooley (733432)

E2 and DPN decrease p65 occupancy and Ac-H4 levels. by Winfred Stacey (3097896)

Deletion of <i>sagA</i> alone results in a decrease in nasopharyngeal infection. by Blake A. Shannon (14197601)

Genes and pathways decreased in 16E6/FN123 HFKs. by Justine Levan (4579156)

“…Fold change shown is the average fold change over all 16E6 HFK cell lines in which that gene was decreased. …”

GXM decreases the trans-endothelial electrical resistance (TEER) and transmigration of <i>C</i>. <i>neoformans</i> through HBECs in a blood brain barrier (BBB) model. by Hiu Ham Lee (15374677)

HIV treatment increases IL-18 but decreases IL-18BP in IEC. by Ossama Allam (5043434)

“…<p>HT-29 monolayers (~ one million cells) were infected with 10⁶ infectious units of NL4.3, 89.6, or treated with Tat (100 ng/ml). …”

Decreased miR-29b/c in GC tissue samples. by He Cui (229445)

<i>Dmxl2</i> knockdown in INS-1E cells decreases glucose-induced insulin release. by Brooke Tata (633065)

“…(B) Seventy-two hours after the transfection of INS-1E cells with <i>Dmxl2-</i>siRNA, <i>Dmxl2</i> mRNA levels had decreased by 75% (error bars: SEM; from three independent experiments). …”

Δ3C virus-induced lymphomas have decreased expression of E2F target genes. by James C. Romero-Masters (4112614)

Mammalian METTL10 is an EF1A1 KMT. by Tadahiro Shimazu (619411)

Subjects:

VRK1 overexpression is seen in human breast cancer and is associated with decreased relapse-free survival. by Aye M. Mon (5714912)

“…The overall median rank of VRK1 mRNA overexpression was 947 (out of 19,273 measured genes) (p = 3.64x10^-28). Data for cancer subtypes are shown in boxes numbered 1–11: 1: benign breast neoplasm (rank 6459, 1.4 fold-change, NS), 2: breast carcinoma (rank 833, 1.5 fold-change, p = 3.83x10^-5), 3: breast phyllodes tumor (rank 512, 1.2 fold-change, p = 0.002), 4: ductal breast carcinoma in situ (rank 1969, 1.5 fold-change, p = 0.002), 5: invasive breast carcinoma (rank 1060, 1.6 fold-change, p = 1.28x10^-5), 6: invasive ductal and invasive lobular breast carcinoma (rank 941, 1.5 fold-change, p = 6.76x10^-22), 7: invasive ductal breast carcinoma (rank 613, 1.5-fold change, p = 2.71x10^-71), 8: invasive lobular breast carcinoma (rank 947, 1.3 fold-change, p = 3.64x10^-28), 9: medullary breast carcinoma (rank 400, 1.8 fold-change, p = 3.25x10^-12), 10: mucinous breast carcinoma (rank 1932, 1.4 fold-change, p = 7.41x10^-10) and 11: tubular breast carcinoma (rank 1253, 1.4 fold-change, p = 1.24x10^-17). …”